According to a newly published market research report by 24LifeSciences, global non-invasive cancer diagnosis market was valued at USD 1.8 billion in 2023 and is projected to reach USD 3.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 2024–2030. Non-invasive cancer diagnostics represent a paradigm shift in oncology, utilizing...